These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2196303)

  • 1. Resistance and allergy to recombinant human insulin.
    Ganz MA; Unterman T; Roberts M; Uy R; Sahgal S; Samter M; Grammer LC
    J Allergy Clin Immunol; 1990 Jul; 86(1):45-51. PubMed ID: 2196303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study.
    Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G
    Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and allergenic potential of animal and human insulins.
    Schernthaner G
    Diabetes Care; 1993 Dec; 16 Suppl 3():155-65. PubMed ID: 8299472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of immune-mediated insulin resistance by human insulin (recombinant DNA).
    Maneschi F; Fineberg SE; Kohner EM
    Diabetes Care; 1982; 5 Suppl 2():175-9. PubMed ID: 6765532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Insulin-resistant Diabetes due to Insulin Antibodies Associated with Eosinophilia.
    Takaya M; Nagao M; Takemitsu S; Nakajima Y; Sugihara H; Uchigata Y; Oikawa S
    Intern Med; 2015; 54(18):2367-71. PubMed ID: 26370863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin antibodies in the pathogenesis of insulin allergy and resistance.
    Witters LA; Ohman JL; Weir GC; Raymond LW; Lowell FC
    Am J Med; 1977 Nov; 63(5):703-9. PubMed ID: 563170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance.
    Grammer LC; Roberts M; Buchanan TA; Fitzsimons R; Metzger BE; Patterson R
    J Lab Clin Med; 1987 Feb; 109(2):141-6. PubMed ID: 3543177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immediate type allergy to insulin (author's transl)].
    Velcovsky HG; Beringhoff B; Federlin K
    Immun Infekt; 1978 Aug; 6(4):146-52. PubMed ID: 150399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy.
    Greenfield JR; Tuthill A; Soos MA; Semple RK; Halsall DJ; Chaudhry A; O'Rahilly S
    Diabet Med; 2009 Jan; 26(1):79-82. PubMed ID: 19125765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects.
    Fireman P; Fineberg SE; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The insulin analog aspart: a safe alternative in insulin allergy.
    Airaghi L; Lorini M; Tedeschi A
    Diabetes Care; 2001 Nov; 24(11):2000. PubMed ID: 11679473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin allergy: background, diagnosis and treatment].
    Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.
    Hirai H; Ogata E; Kikuchi N; Kohno T; Machii N; Hasegawa K; Watanabe T; Satoh H
    J Med Case Rep; 2016 Jul; 10():202. PubMed ID: 27456688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor binding studies and clinical effects of human insulin (recombinant DNA): studies in patients with newly diagnosed type i diabetes, type II diabetes, insulin resistance (type A and type B), insulin antibodies, insulin allergy, and "brittle" diabetes.
    Schlüter KJ; Kerp L
    Diabetes Care; 1982; 5 Suppl 2():152-60. PubMed ID: 6765528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated insulin resistance treated by cessation of insulin administration.
    Hara K; Tobe K; Uchigata Y; Nakazono M; Yasuda K; Terauchi Y; Iwamoto Y; Akanuma Y; Kimura S; Kadowaki T
    Intern Med; 2000 Feb; 39(2):143-5. PubMed ID: 10732832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe insulin-resistant diabetes mellitus associated with hypereosinophilic syndrome.
    Uriuhara A; Morita S; Kuroda S; Fumoto M; Araki S; Aoyama N; Amano K; Hayashi Y; Yokono K; Kasuga M
    Intern Med; 1994 Oct; 33(10):632-6. PubMed ID: 7827382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin allergy: re-evaluation after two decades.
    Patterson R; Roberts M; Grammer LC
    Ann Allergy; 1990 May; 64(5):459-62. PubMed ID: 2186675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin.
    Davidson JK; Fineberg SE; De Meyts P; Fineberg NS; Galloway JA
    Diabetes Care; 1992 May; 15(5):702-4. PubMed ID: 1516491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin allergy in type II diabetes: rapid desensitization].
    Ruíz Barrera E; Martínez-Cario Cueto S
    Rev Alerg Mex; 1994; 41(1):19-24. PubMed ID: 8087231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.